JPWO2023139090A5 - - Google Patents

Info

Publication number
JPWO2023139090A5
JPWO2023139090A5 JP2024541983A JP2024541983A JPWO2023139090A5 JP WO2023139090 A5 JPWO2023139090 A5 JP WO2023139090A5 JP 2024541983 A JP2024541983 A JP 2024541983A JP 2024541983 A JP2024541983 A JP 2024541983A JP WO2023139090 A5 JPWO2023139090 A5 JP WO2023139090A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
less
domain
galectin
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503701A5 (https=
JP2025503701A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/051073 external-priority patent/WO2023139090A1/en
Publication of JP2025503701A publication Critical patent/JP2025503701A/ja
Publication of JP2025503701A5 publication Critical patent/JP2025503701A5/ja
Publication of JPWO2023139090A5 publication Critical patent/JPWO2023139090A5/ja
Pending legal-status Critical Current

Links

JP2024541983A 2022-01-18 2023-01-18 Ｆａｂ断片の噴霧 Pending JP2025503701A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB202200592 2022-01-18
GB2200592.0 2022-01-18
PCT/EP2023/051073 WO2023139090A1 (en) 2022-01-18 2023-01-18 Nebulization of fab fragments

Publications (3)

Publication Number Publication Date
JP2025503701A JP2025503701A (ja) 2025-02-04
JP2025503701A5 JP2025503701A5 (https=) 2026-01-19
JPWO2023139090A5 true JPWO2023139090A5 (https=) 2026-01-19

Family

ID=85036924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541983A Pending JP2025503701A (ja) 2022-01-18 2023-01-18 Ｆａｂ断片の噴霧

Country Status (10)

Country Link
US (1) US20250059284A1 (https=)
EP (1) EP4466009A1 (https=)
JP (1) JP2025503701A (https=)
KR (1) KR20240133723A (https=)
CN (1) CN118434440A (https=)
AU (1) AU2023210422A1 (https=)
CA (1) CA3236113A1 (https=)
IL (1) IL314365A (https=)
MX (1) MX2024007659A (https=)
WO (1) WO2023139090A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2461546B (en) 2008-07-02 2010-07-07 Argen X Bv Antigen binding polypeptides
MX2020010821A (es) 2018-04-13 2021-01-15 Argenx Iip Bv Anticuerpos contra galectina-10.

Similar Documents

Publication Publication Date Title
JP6392422B2 (ja) 吸入用の一価金属カチオン乾燥粉末
CN105640925B (zh) 干燥粉末配方及用于治疗肺部疾病的方法
EP2448571B1 (en) Respirably dry powder comprising calcium lactate, sodium chloride and leucine
EP4051708B1 (en) Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof
KR20120003459A (ko) 폐 질환 치료용 건조 분말 제형 및 방법
JP2017512193A5 (https=)
IL271132B1 (en) Dry powder aclidinium salt pharmaceutical composition for treatment of copd
CN113797333A (zh) 一种新型冠状病毒抗体的药物组合物及其用途
JP2003531866A (ja) 抗体を用いた呼吸器疾患の組合せ治療法
JP2007506681A5 (https=)
JPWO2023139090A5 (https=)
TW202228690A (zh) 茚達特羅(indacaterol)之液體調配物
JPWO2022231978A5 (https=)
HK40124015A (en) Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof
HK40072413A (en) Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof
HK40072413B (en) Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof
WO2021211854A1 (en) Inhalable formulation of a solution containing tiotropium bromide
TW202529811A (zh) 胸腺基質淋巴細胞生成素（ｔｓｌｐ）結合片段之組成物及其使用方法
JPWO2023130010A5 (https=)